Bath & Body Works (NYSE:BBWI) Stock Price Expected to Rise, Barclays Analyst Says

Bath & Body Works (NYSE:BBWI) had its price objective increased by analysts at Barclays from $28.00 to $34.00 in a research note issued on Tuesday,Benzinga reports. The firm presently has an “underweight” rating on the stock. Barclays‘s price objective points to a potential downside of 5.35% from the company’s previous close.

Several other research firms also recently commented on BBWI. Evercore ISI cut their target price on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a research report on Wednesday, August 28th. JPMorgan Chase & Co. reduced their target price on shares of Bath & Body Works from $42.00 to $39.00 and set a “neutral” rating on the stock in a research note on Thursday, August 29th. Bank of America dropped their target price on shares of Bath & Body Works from $54.00 to $45.00 and set a “buy” rating for the company in a research report on Thursday, August 29th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Bath & Body Works from $57.00 to $54.00 and set a “buy” rating on the stock in a research report on Monday, August 26th. Finally, The Goldman Sachs Group dropped their price objective on shares of Bath & Body Works from $60.00 to $49.00 and set a “buy” rating for the company in a report on Thursday, August 29th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $41.88.

Bath & Body Works Stock Performance

Shares of Bath & Body Works stock opened at $35.92 on Tuesday. The firm has a market cap of $7.87 billion, a P/E ratio of 8.83, a price-to-earnings-growth ratio of 1.14 and a beta of 1.79. The firm’s 50-day simple moving average is $30.81 and its 200-day simple moving average is $35.65. Bath & Body Works has a twelve month low of $26.20 and a twelve month high of $52.99.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.54 billion. On average, equities analysts forecast that Bath & Body Works will post 3.18 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Gina Boswell acquired 6,000 shares of the company’s stock in a transaction on Wednesday, October 9th. The stock was purchased at an average cost of $29.64 per share, with a total value of $177,840.00. Following the acquisition, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This trade represents a 2.53 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 0.27% of the stock is currently owned by insiders.

Institutional Investors Weigh In On Bath & Body Works

Several institutional investors have recently modified their holdings of the business. First Community Trust NA acquired a new position in Bath & Body Works in the second quarter valued at approximately $30,000. True Wealth Design LLC raised its position in shares of Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after acquiring an additional 1,054 shares during the last quarter. Livforsakringsbolaget Skandia Omsesidigt lifted its stake in shares of Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock valued at $38,000 after purchasing an additional 900 shares during the period. Wilmington Savings Fund Society FSB bought a new position in shares of Bath & Body Works in the 3rd quarter worth $39,000. Finally, TD Private Client Wealth LLC grew its stake in shares of Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock worth $54,000 after purchasing an additional 331 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.